Developer docs
API playgroundTry for free, no card

Search company profiles

Halloran Consulting

Full company profile

uuid0006q6d

Namestring
Halloran Consulting
Legal namestring
Halloran Consulting Group, Inc.
Websiteurl
hallorancg.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Halloran Consulting Group, Inc. is a privately held life science consulting firm founded in 1998 and headquartered in Cambridge, Massachusetts, with additional offices in San Diego and Boston. The firm provides integrated consulting services across the full drug and product development lifecycle, organized into five service phases: Discovery, Preclinical, Clinical Development, Commercialization, and All Stages. Core offerings include regulatory affairs (IND/NDA/BLA preparation, eCTD submissions, FDA meeting strategy, special designations), clinical operations (trial leadership, medical writing, program management), GxP quality management system development, and strategic advisory including biopharma due diligence and CDMO/CRO selection.

Halloran serves primarily early- and mid-stage biotech companies, with secondary exposure to MedTech and pharmaceutical clients. The firm does not develop proprietary technology products; its value is delivered through senior consulting professionals with deep FDA engagement experience spanning CDER, CBER, and CDRH divisions. The firm's stated track record includes thousands of regulatory submissions handled over more than two decades. Revenue is generated through project-based consulting engagements with quote-based pricing tied to scope, duration, and team composition—no public pricing tiers or SaaS/productized offerings are disclosed.

The go-to-market model is direct B2B sales supported by thought-leadership content (insights blog, webinars), proprietary industry events (CORE, Breadth in Bioscience Symposium), and participation in sector conferences. Customer acquisition relies on relationship-driven BD, website contact forms, and referral networks within the life sciences ecosystem. Halloran is founder-led (Laurie Halloran) and operates as an independent, privately held corporation (Halloran Consulting Group, Inc., domiciled in Massachusetts) with no disclosed institutional investors, funding rounds, M&A activity, or parent company.

Short descriptiontext

Halloran Consulting Group is a privately held life science consulting firm serving biotech, MedTech, and pharma clients with integrated regulatory, clinical development, quality management, and commercialization advisory services across the full product development lifecycle, from discovery through market launch.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science consulting, regulatory affairs consulting, clinical development consulting, quality management systems, medical device regulatory
Industry2 codes
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting
SECONDARYBPAHACAB
Operations & Process Improvement Consulting
NAICS code1 code
  • Management Consulting Services54161
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Life Science Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Regulatory & Compliance Consulting Services
TypeProfessional Services
Description

Halloran generates revenue through project-based consulting engagements across all phases of drug and product development, including regulatory affairs, clinical development, quality management, and commercialization support. Services are tailored to biotech, MedTech, and pharmaceutical companies from early discovery through market launch. Engagements range from strategic advising and regulatory submissions to clinical trial leadership, role-based staffing, and inspection readiness.

hallorancg.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Halloran Consulting Group is a life science consulting firm that provides regulatory affairs, clinical operations, quality management, and strategic advisory services to biotech, MedTech, and pharmaceutical companies. Services are organized into five phases—Discovery, Preclinical, Clinical Development, Commercialization, and All Stages—spanning the full product development lifecycle from early discovery through market launch and post-approval compliance.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Halloran Consulting Group is a life science consulting firm that offers a comprehensive suite of consulting services organized into five service phases: Discovery Phase Services, Preclinical Phase Services, Clinical Development Phase Services, Commercialization Phase Services, and All Stages Services. Their integrated development approach spans from early drug discovery through commercialization, providing strategic advising, regulatory guidance, quality management, clinical operations, and program leadership. The company serves biotech, MedTech, and pharmaceutical companies seeking to bring drugs, devices, and therapies to market.

Product and service5 records
1Discovery Phase Services
CategoryConsulting Services
Description

Consulting services to help biotech, medical device, and pharmaceutical companies streamline discovery processes and improve pathways to regulatory and commercial launch, including indication assessment, landscape analysis, and strategic advising.

2Preclinical Phase Services
CategoryConsulting Services
Description

Consulting services to help life science companies navigate preclinical testing, including clinical development planning, health authority meeting support, integrated development plans, regulatory IND readiness, GxP QMS development, and CDMO vendor selection.

3Clinical Development Phase Services
CategoryConsulting Services
Description

Comprehensive consulting support for advancing through clinical development and health authority review, including IND applications, clinical trial leadership, medical writing, GxP quality assessment, regulatory operations, marketing applications, and inspection readiness.

4Commercialization Phase Services
CategoryConsulting Services
Description

Consulting services to support post-approval stage including organizational design and transformation, GxP quality assessment and remediation, and regulatory CMC support to bring products to market and manage ongoing compliance.

5All Stages Services
CategoryConsulting Services
Description

End-to-end consulting services covering strategic advising, audits and oversight, biopharma due diligence, program leadership and management, technology enablement, CRO/CDMO selection, and special designation assessment for companies at any development stage.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Pro-ficiency provides clinical trial training, simulation, and regulatory consulting services to pharma and biotech. Comparable as a specialized life sciences services firm helping clients navigate FDA interactions and clinical operations, though with a stronger technology-enabled training angle.

TypeDirect peer
Description

NDA Partners is a regulatory and drug development consulting firm serving pharma and biotech clients. Directly comparable to Halloran in providing FDA strategy, NDA/BLA preparation, and senior regulatory advisor engagements for life science companies.

TypeBroad incumbent
Description

Parexel is a major global CRO with a regulatory and clinical consulting practice serving pharma and biotech across all development phases. Comparable in service scope (regulatory, clinical, quality) but operates at significantly larger scale with full-service CRO delivery.

TypeDirect peer
Description

Putnam Associates provides strategy consulting to biopharmaceutical, medical device, and diagnostics clients on pricing, market access, and product strategy. Comparable as a specialized life sciences strategy consultancy serving similar biotech and MedTech buyers.

TypeBroad incumbent
Description

Charles River Associates is a broad management consulting firm with a sizeable life sciences practice serving pharma, biotech, and MedTech clients. Comparable target customer base but offers services as part of a wider industry portfolio rather than specializing exclusively in life sciences regulatory/clinical.

6Camargo Pharmaceutical Services
TypeDirect peer
Description

Camargo Pharmaceutical Services is a regulatory strategy and drug development consulting firm serving biotech and pharma, with deep experience in 505(b)(2), ANDA, and NDA pathways. Closely comparable to Halloran's regulatory affairs and clinical development services.

TypeBroad incumbent
Description

IQVIA is the largest CRO and life science technology/consulting platform, offering regulatory affairs, clinical, and quality consulting as part of a broader portfolio. Overlaps with Halloran's regulatory and clinical advisory offerings but at much greater scale and with technology and data differentiators.

TypeDirect peer
Description

Health Advances is a strategy consulting firm exclusively focused on life sciences, advising biotech, MedTech, and diagnostics companies on corporate strategy, market access, and product development. Highly comparable in target market and B2B life science advisory model.

TypeEmerging player
Description

Smaller specialty CROs and quality/regulatory boutiques (e.g., BioPlus Consulting, Azzur Group) compete with Halloran for biotech engagements in QMS, validation, and FDA inspection readiness. They overlap in target customer (early-stage biotech) and service type (quality and regulatory consulting).

10Defined Health (a Panzura Group company)
TypeDirect peer
Description

Defined Health is a strategy consulting firm focused exclusively on the life sciences industry, advising biotech and pharma clients on business development, therapeutic strategy, and corporate transactions. Comparable as a specialized life sciences strategy consultancy with similar client profile.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Halloran Consulting

Life Science Consultinghallorancg.com

Halloran Consulting Group is a privately held life science consulting firm serving biotech, MedTech, and pharma clients with integrated regulatory, clinical development, quality management, and commercialization advisory services across the full product development lifecycle, from discovery through market launch.

What Halloran Consulting does

Halloran Consulting Group, Inc. is a privately held life science consulting firm founded in 1998 and headquartered in Cambridge, Massachusetts, with additional offices in San Diego and Boston. The firm provides integrated consulting services across the full drug and product development lifecycle, organized into five service phases: Discovery, Preclinical, Clinical Development, Commercialization, and All Stages. Core offerings include regulatory affairs (IND/NDA/BLA preparation, eCTD submissions, FDA meeting strategy, special designations), clinical operations (trial leadership, medical writing, program management), GxP quality management system development, and strategic advisory including biopharma due diligence and CDMO/CRO selection.

Halloran serves primarily early- and mid-stage biotech companies, with secondary exposure to MedTech and pharmaceutical clients. The firm does not develop proprietary technology products; its value is delivered through senior consulting professionals with deep FDA engagement experience spanning CDER, CBER, and CDRH divisions. The firm's stated track record includes thousands of regulatory submissions handled over more than two decades. Revenue is generated through project-based consulting engagements with quote-based pricing tied to scope, duration, and team composition—no public pricing tiers or SaaS/productized offerings are disclosed.

The go-to-market model is direct B2B sales supported by thought-leadership content (insights blog, webinars), proprietary industry events (CORE, Breadth in Bioscience Symposium), and participation in sector conferences. Customer acquisition relies on relationship-driven BD, website contact forms, and referral networks within the life sciences ecosystem. Halloran is founder-led (Laurie Halloran) and operates as an independent, privately held corporation (Halloran Consulting Group, Inc., domiciled in Massachusetts) with no disclosed institutional investors, funding rounds, M&A activity, or parent company.

Halloran Consulting firmographics

Firmographics
Name
Halloran Consulting
Legal name
Halloran Consulting Group, Inc.
Website
https://hallorancg.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
51–100 employees
Short description
Halloran Consulting Group is a privately held life science consulting firm serving biotech, MedTech, and pharma clients with integrated regulatory, clinical development, quality management, and commercialization advisory services across the full product development lifecycle, from discovery through market launch.
Ownership category
akta.pro rank

Halloran Consulting industry classification

Industry
Product category
Life Science Consulting
NAICS
Management Consulting Services (54161)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting
SECONDARYBPAHACAB
Operations & Process Improvement Consulting

Keywords

  • Life science consulting
  • Regulatory affairs consulting
  • Clinical development consulting
  • Quality management systems
  • Medical device regulatory

Where Halloran Consulting is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Halloran Consulting business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Regulatory & Compliance Consulting Services: Halloran generates revenue through project-based consulting engagements across all phases of drug and product development, including regulatory affairs, clinical development, quality management, and commercialization support. Services are tailored to biotech, MedTech, and pharmaceutical companies from early discovery through market launch. Engagements range from strategic advising and regulatory submissions to clinical trial leadership, role-based staffing, and inspection readiness.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Halloran Consulting product offering

Product offering

Core offering

Halloran Consulting Group is a life science consulting firm that provides regulatory affairs, clinical operations, quality management, and strategic advisory services to biotech, MedTech, and pharmaceutical companies. Services are organized into five phases—Discovery, Preclinical, Clinical Development, Commercialization, and All Stages—spanning the full product development lifecycle from early discovery through market launch and post-approval compliance.

Product overview

Halloran Consulting Group is a life science consulting firm that offers a comprehensive suite of consulting services organized into five service phases: Discovery Phase Services, Preclinical Phase Services, Clinical Development Phase Services, Commercialization Phase Services, and All Stages Services. Their integrated development approach spans from early drug discovery through commercialization, providing strategic advising, regulatory guidance, quality management, clinical operations, and program leadership. The company serves biotech, MedTech, and pharmaceutical companies seeking to bring drugs, devices, and therapies to market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Discovery Phase Services Consulting services to help biotech, medical device, and pharmaceutical companies streamline discovery processes and improve pathways to regulatory and commercial launch, including indication assessment, landscape analysis, and strategic advising.
  • Preclinical Phase Services Consulting services to help life science companies navigate preclinical testing, including clinical development planning, health authority meeting support, integrated development plans, regulatory IND readiness, GxP QMS development, and CDMO vendor selection.
  • Clinical Development Phase Services Comprehensive consulting support for advancing through clinical development and health authority review, including IND applications, clinical trial leadership, medical writing, GxP quality assessment, regulatory operations, marketing applications, and inspection readiness.
  • Commercialization Phase Services Consulting services to support post-approval stage including organizational design and transformation, GxP quality assessment and remediation, and regulatory CMC support to bring products to market and manage ongoing compliance.
  • All Stages Services End-to-end consulting services covering strategic advising, audits and oversight, biopharma due diligence, program leadership and management, technology enablement, CRO/CDMO selection, and special designation assessment for companies at any development stage.

Companies that use Halloran Consulting

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Halloran Consulting technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Halloran Consulting partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Halloran Consulting competitors and assessment

Company assessment

Emerging players

  • Pro-ficiency (Pro-ficiency Clinical & Regulatory Solutions): Pro-ficiency provides clinical trial training, simulation, and regulatory consulting services to pharma and biotech. Comparable as a specialized life sciences services firm helping clients navigate FDA interactions and clinical operations, though with a stronger technology-enabled training angle.
  • Lindus Health / Experienced CROs for Biotech: Smaller specialty CROs and quality/regulatory boutiques (e.g., BioPlus Consulting, Azzur Group) compete with Halloran for biotech engagements in QMS, validation, and FDA inspection readiness. They overlap in target customer (early-stage biotech) and service type (quality and regulatory consulting).

Direct peers

  • NDA Partners: NDA Partners is a regulatory and drug development consulting firm serving pharma and biotech clients. Directly comparable to Halloran in providing FDA strategy, NDA/BLA preparation, and senior regulatory advisor engagements for life science companies.
  • Putnam Associates: Putnam Associates provides strategy consulting to biopharmaceutical, medical device, and diagnostics clients on pricing, market access, and product strategy. Comparable as a specialized life sciences strategy consultancy serving similar biotech and MedTech buyers.
  • Camargo Pharmaceutical Services: Camargo Pharmaceutical Services is a regulatory strategy and drug development consulting firm serving biotech and pharma, with deep experience in 505(b)(2), ANDA, and NDA pathways. Closely comparable to Halloran's regulatory affairs and clinical development services.
  • Health Advances: Health Advances is a strategy consulting firm exclusively focused on life sciences, advising biotech, MedTech, and diagnostics companies on corporate strategy, market access, and product development. Highly comparable in target market and B2B life science advisory model.
  • Defined Health (a Panzura Group company): Defined Health is a strategy consulting firm focused exclusively on the life sciences industry, advising biotech and pharma clients on business development, therapeutic strategy, and corporate transactions. Comparable as a specialized life sciences strategy consultancy with similar client profile.

Broad incumbents

  • Parexel (Consulting & Regulatory): Parexel is a major global CRO with a regulatory and clinical consulting practice serving pharma and biotech across all development phases. Comparable in service scope (regulatory, clinical, quality) but operates at significantly larger scale with full-service CRO delivery.
  • Charles River Associates (Life Sciences Practice): Charles River Associates is a broad management consulting firm with a sizeable life sciences practice serving pharma, biotech, and MedTech clients. Comparable target customer base but offers services as part of a wider industry portfolio rather than specializing exclusively in life sciences regulatory/clinical.
  • IQVIA (Consulting & Regulatory Services): IQVIA is the largest CRO and life science technology/consulting platform, offering regulatory affairs, clinical, and quality consulting as part of a broader portfolio. Overlaps with Halloran's regulatory and clinical advisory offerings but at much greater scale and with technology and data differentiators.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Halloran Consulting social profiles

Digital presence

Halloran Consulting financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Halloran Consulting leadership team

Management profile

Number of profiles

Profiles1 record

Halloran Consulting funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Halloran Consulting M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Halloran Consulting

What does Halloran Consulting do?

Halloran Consulting Group is a life science consulting firm that provides regulatory affairs, clinical operations, quality management, and strategic advisory services to biotech, MedTech, and pharmaceutical companies. Services are organized into five phases—Discovery, Preclinical, Clinical Development, Commercialization, and All Stages—spanning the full product development lifecycle from early discovery through market launch and post-approval compliance.

Is Halloran Consulting a public or private company?

Halloran Consulting is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Halloran Consulting founded?

Halloran Consulting was founded in 1998. It employs 51 to 100 people.

Where is Halloran Consulting based?

Halloran Consulting is headquartered in Boston, United States, in the North America region.

How does Halloran Consulting make money?

One revenue line is on record: regulatory & Compliance Consulting Services.

Who are Halloran Consulting's main competitors?

Emerging players on record are Pro-ficiency (Pro-ficiency Clinical & Regulatory Solutions) and Lindus Health / Experienced CROs for Biotech. Direct peers are NDA Partners, Putnam Associates, Camargo Pharmaceutical Services, Health Advances and Defined Health (a Panzura Group company). Broad incumbents are Parexel (Consulting & Regulatory), Charles River Associates (Life Sciences Practice) and IQVIA (Consulting & Regulatory Services).

Does Halloran Consulting have an API?

No public API is recorded for Halloran Consulting.

What industry is Halloran Consulting in?

Halloran Consulting's product category is Life Science Consulting. Its primary akta.pro industry code is BPAHACAA, Strategy & Corporate Development Consulting, with a secondary code of BPAHACAB, Operations & Process Improvement Consulting. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals